Skip to main content
. Author manuscript; available in PMC: 2010 Jan 14.
Published in final edited form as: Pharmacol Biochem Behav. 2008 Oct;90(4):540–544. doi: 10.1016/j.pbb.2008.04.010

Fig. 2.

Fig. 2

Anti-dyskinetic effect of ACP-103. Dyskinesia severity score is shown as a function of ACP-103 dose in combination with levodopa in MPTP-treated monkeys. The means and standard errors of the means for each group (n=5) are shown. Statistical difference from vehicle (P<0.01) is indicated by asterisks.